ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome

Yen Yu Lu, Chen Chuan Cheng, Yao Chang Chen, Shih Ann Chen, Yi Jen Chen

研究成果: 雜誌貢獻文章同行評審

14 引文 斯高帕斯(Scopus)


Background Long QT syndrome (LQTS) is associated with a high incidence of atrial fibrillation (AF), but the underlying mechanisms are unclear. Pulmonary veins (PVs) play a critical role in AF genesis. Type 3 LQTS increases late sodium current (INa,L), which may increase PV arrhythmogenesis and AF. Therefore, this study examines PV arrhythmogenesis in anemonia sulcata toxin II (ATX-II)-induced type 3 LQTS and evaluates whether the INa,L inhibitor ranolazine can suppress PV arrhythmogenesis. Materials and methods Conventional microelectrodes were used to record the action potentials (AP) and contractility in isolated rabbit PV specimens before and after ATX-II administration with or without ranolazine. Results Anemonia sulcata toxin II (100nM) increased the PV spontaneous rates from 2·0±0·1 to 2·9±0·2Hz (n=7), induced PV burst firing (100%) with the genesis of early afterdepolarization (EAD) (86%) and prolonged the AP duration. Ranolazine (0·1, 1 and 10μM) dose dependently reduced the PV spontaneous rates from 2·5±0·2 to 2·3±0·2Hz, 1·9±0·2 and 1·5±0·3Hz (PNa,L enhancer ATX-II can increase PV arrhythmogenesis, which can be attenuated or blocked by ranolazine. This suggests that AF may be related to type 3 LQTS through increased INa,L.

頁(從 - 到)823-831
期刊European Journal of Clinical Investigation
出版狀態已發佈 - 8月 2012

ASJC Scopus subject areas

  • 醫藥 (全部)
  • 臨床生物化學
  • 生物化學


深入研究「ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome」主題。共同形成了獨特的指紋。